Clinical Trials in Daejeon, Korea
3 recruiting
Showing 1–3 of 3 trials
Recruiting
Phase 3
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis
Lupus Nephritis
Novartis Pharmaceuticals462 enrolled188 locationsNCT05126277
Recruiting
A 24-week Prospective, Open-label, Multicenter, Single-arm rPMS Study in Real-world Setting for Atectura®
Asthma
Novartis Pharmaceuticals600 enrolled18 locationsNCT05217810
Recruiting
Regulatory Post-Marketing Surveillance Study for Brolucizumab
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals3,000 enrolled28 locationsNCT04985487